Year |
Citation |
Score |
2023 |
Sziraki A, Zhong Y, Neltner AM, Niedowicz D, Rogers CB, Wilcock DM, Nehra G, Neltner JH, Smith RR, Hartz AM, Cao J, Nelson PT. A high-throughput single-cell RNA expression profiling method identifies human pericyte markers. Neuropathology and Applied Neurobiology. e12942. PMID 37812061 DOI: 10.1111/nan.12942 |
0.615 |
|
2018 |
Hartz A, Schulz J, Sokola B, Bauer B. CADD-16. DUAL PI3K/Akt INHIBITION TO OVERCOME THE P-gp/BCRP DRUG EFFLUX SYSTEM FOR IMPROVED DRUG DELIVERY IN GLIOBLASTOMA THERAPY Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.1161 |
0.339 |
|
2017 |
Hartz AM, Pekcec A, Soldner EL, Zhong Y, Schlichtiger J, Bauer B. P-gp protein expression and transport activity in rodent seizure models and human epilepsy. Molecular Pharmaceutics. PMID 28195743 DOI: 10.1021/Acs.Molpharmaceut.6B00770 |
0.49 |
|
2017 |
Małecki A, Skipor-Lahuta J, Toborek M, Abbott NJ, Antonetti DA, Su EJ, Lawrence DA, Atış M, Akcan U, Yılmaz CU, Orhan N, Düzgün P, Ceylan UD, Arıcan N, Karahüseyinoğlu S, ... ... Hartz A, et al. Abstracts from the 20th International Symposium on Signal Transduction at the Blood-Brain Barriers Fluids and Barriers of the Cns. 14. DOI: 10.1186/S12987-017-0071-4 |
0.466 |
|
2016 |
Rempe RG, Hartz AM, Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27323783 DOI: 10.1177/0271678X16655551 |
0.443 |
|
2016 |
Hartz AM, Zhong Y, Wolf A, LeVine H, Miller DS, Bauer B. Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 1930-41. PMID 26865616 DOI: 10.1523/Jneurosci.0350-15.2016 |
0.598 |
|
2015 |
Akkaya BG, Zolnerciks JK, Ritchie TK, Bauer B, Hartz AM, Sullivan JA, Linton KJ. The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1. Molecular Membrane Biology. 1-7. PMID 26006083 DOI: 10.3109/09687688.2015.1023378 |
0.334 |
|
2011 |
Jacob A, Hartz AM, Potin S, Coumoul X, Yousif S, Scherrmann JM, Bauer B, Declèves X. Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels. Fluids and Barriers of the Cns. 8: 23. PMID 21867498 DOI: 10.1186/2045-8118-8-23 |
0.458 |
|
2011 |
Agarwal S, Hartz AM, Elmquist WF, Bauer B. Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up. Current Pharmaceutical Design. 17: 2793-802. PMID 21827403 |
0.491 |
|
2011 |
Shukla S, Skoumbourdis AP, Walsh MJ, Hartz AM, Fung KL, Wu CP, Gottesman MM, Bauer B, Thomas CJ, Ambudkar SV. Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters. Molecular Pharmaceutics. 8: 1292-302. PMID 21630681 DOI: 10.1021/Mp2001022 |
0.408 |
|
2010 |
Hartz AM, Bauer B. Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy. Molecular Interventions. 10: 293-304. PMID 21045243 DOI: 10.1124/mi.10.5.6 |
0.454 |
|
2010 |
Hartz AM, Mahringer A, Miller DS, Bauer B. 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1742-55. PMID 20216549 DOI: 10.1038/jcbfm.2010.36 |
0.613 |
|
2010 |
Hartz AM, Miller DS, Bauer B. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Molecular Pharmacology. 77: 715-23. PMID 20101004 DOI: 10.1124/mol.109.061754 |
0.567 |
|
2009 |
Stenehjem DD, Hartz AM, Bauer B, Anderson GW. Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier. Future Medicinal Chemistry. 1: 1623-41. PMID 21425983 DOI: 10.4155/Fmc.09.137 |
0.483 |
|
2009 |
Hartz AM, Notenboom S, Bauer B. Signaling to P-glycoprotein-A new therapeutic target to treat drug-resistant epilepsy? Drug News & Perspectives. 22: 393-7. PMID 19890496 DOI: 10.1358/dnp.2009.22.7.1401354 |
0.343 |
|
2009 |
Pekcec A, Unkrüer B, Schlichtiger J, Soerensen J, Hartz AM, Bauer B, van Vliet EA, Gorter JA, Potschka H. Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation. The Journal of Pharmacology and Experimental Therapeutics. 330: 939-47. PMID 19494186 DOI: 10.1124/Jpet.109.152520 |
0.471 |
|
2009 |
Zibell G, Unkrüer B, Pekcec A, Hartz AM, Bauer B, Miller DS, Potschka H. Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition. Neuropharmacology. 56: 849-55. PMID 19371577 DOI: 10.1016/j.neuropharm.2009.01.009 |
0.579 |
|
2008 |
Miller DS, Bauer B, Hartz AM. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacological Reviews. 60: 196-209. PMID 18560012 DOI: 10.1124/Pr.107.07109 |
0.671 |
|
2008 |
Hartz AM, Bauer B, Block ML, Hong JS, Miller DS. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2723-33. PMID 18474546 DOI: 10.1096/Fj.08-106997 |
0.621 |
|
2008 |
Bauer B, Hartz AM, Lucking JR, Yang X, Pollack GM, Miller DS. Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1222-34. PMID 18349876 DOI: 10.1038/Jcbfm.2008.16 |
0.611 |
|
2008 |
Bauer B, Hartz AM, Pekcec A, Toellner K, Miller DS, Potschka H. Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Molecular Pharmacology. 73: 1444-53. PMID 18094072 DOI: 10.1124/Mol.107.041210 |
0.642 |
|
2007 |
Bauer B, Hartz AM, Miller DS. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Molecular Pharmacology. 71: 667-75. PMID 17132686 DOI: 10.1124/Mol.106.029512 |
0.643 |
|
2006 |
Bauer B, Yang X, Hartz AM, Olson ER, Zhao R, Kalvass JC, Pollack GM, Miller DS. In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Molecular Pharmacology. 70: 1212-9. PMID 16837625 DOI: 10.1124/Mol.106.023796 |
0.654 |
|
2006 |
Hartz AM, Bauer B, Fricker G, Miller DS. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Molecular Pharmacology. 69: 462-70. PMID 16278373 DOI: 10.1124/Mol.105.017954 |
0.678 |
|
2006 |
Hartz AM, Shen AN, Ding Y, Bauer B. P3-203: P-GLYCOPROTEIN IN ALZHEIMER'S DISEASE: NOVEL STRATEGIES TO IMPROVE Aβ CLEARANCE Alzheimer's & Dementia. 14: P1145-P1146. DOI: 10.1016/J.Jalz.2018.06.1562 |
0.311 |
|
2005 |
Bauer B, Hartz AM, Fricker G, Miller DS. Modulation of p-glycoprotein transport function at the blood-brain barrier. Experimental Biology and Medicine (Maywood, N.J.). 230: 118-27. PMID 15673560 DOI: 10.1177/153537020523000206 |
0.717 |
|
2005 |
Hartz A, Bauer B, Baehr C, Miller D, Fricker G. Drug Delivery Across the Blood-Brain Barrier Current Nanoscience. 1: 203-209. DOI: 10.2174/157341305774642948 |
0.664 |
|
2004 |
Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Molecular Pharmacology. 66: 413-9. PMID 15322232 DOI: 10.1124/Mol.66.3 |
0.717 |
|
2004 |
Hartz AM, Bauer B, Fricker G, Miller DS. Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Molecular Pharmacology. 66: 387-94. PMID 15322229 DOI: 10.1124/Mol.104.001503 |
0.644 |
|
Show low-probability matches. |